Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis

Nephrology

Volumn 20, Issue 11, 2015, Pages 832-842

  Mei, Wenjuan ^a   Peng, Zhangzhe ^a   Lu, Miaomiao ^a   Liu, Chunyan ^a   Deng, Zhenghao ^a   Xiao, Yun ^a   Liu, Jishi ^a   He, Ying ^a   Yuan, Qiongjing ^a   Yuan, Xiangning ^a   Tang, Damu ^b   Yang, Huixiang ^a   Tao, Lijian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

apoptosis; Peroxiredoxin 1; renal tubular epithelial cells; renal tubulointerstitial fibrosis

Indexed keywords

ANTIFIBROTIC AGENT; FLUOROFENIDONE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXIREDOXIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 5-METHYL-1-(3-FLUOROPHENYL)-2-(1H)-PYRIDONE; PEROXIREDOXIN; PRDX1 PROTEIN, HUMAN; PRDX1 PROTEIN, RAT; PYRIDONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RENAL PROTECTION; RENAL TUBULOINTERSTITIAL FIBROSIS; RNA INTERFERENCE; UPREGULATION; URETER OBSTRUCTION; ADOLESCENT; ADULT; AGED; ANIMAL; CELL LINE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; FIBROSIS; GENETIC TRANSFECTION; GENETICS; KIDNEY; KIDNEY DISEASES; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EPITHELIAL CELLS; FEMALE; FIBROSIS; HUMANS; HYDROGEN PEROXIDE; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIREDOXINS; PHOSPHORYLATION; PYRIDONES; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; URETERAL OBSTRUCTION; YOUNG ADULT;

EID: 84943249914     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12515     Document Type: Article

References (37)

1. Kuncio GS, Neilson EG, Haverty T,. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991; 39: 550-556.
2. Harris RC, Neilson EG,. Toward a unified theory of renal progression. Annu. Rev. Med. 2006; 57: 365-380.
3. Zeisberg M, Neilson EG,. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2010; 21: 1819-1834.
4. Hofmann B, Hecht HJ, Flohe L,. Peroxiredoxins. Biol. Chem. 2002; 383: 347-364.
5. Wood ZA, Schroder E, Robin HJ, Poole LB,. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003; 28: 32-40.
6. Rhee SG, Kang SW, Chang TS, Jeong W, Kim K,. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 2001; 52: 35-41.
7. Ishii T, Warabi E, Yanagawa T,. Novel roles of peroxiredoxins in inflammation, cancer and innate immunity. J. Clin. Biochem. Nutr. 2012; 50: 91-105.
8. Kim SY, Kim TJ, Lee KY,. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett. 2008; 582: 1913-1918.
9. Kim YJ, Lee WS, Ip C, Chae HZ, Park EM, Park YM,. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res. 2006; 66: 7136-7142.
10. Gertz M, Fischer F, Leipelt M, Wolters D, Steegborn C,. Identification of Peroxiredoxin 1 as a novel interaction partner for the lifespan regulator protein p66Shc. Aging (Albany NY) 2009; 1: 254-265.
11. Li BX, Tang YT, Wang W, et al. Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy. Mol. Cell. Biochem. 2011; 354: 263-273.
12. Yuan Q, Wang R, Peng Y, et al. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-beta(1)-induced fibroblast activation. Am. J. Nephrol. 2011; 34: 181-194.
13. Qin J, Xie YY, Huang L, et al. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis. Nephrology (Carlton) 2013; 18: 690-699.
14. Yuan Q, Wang L, Zhang F, et al. Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells. Pharmazie 2011; 66: 961-967.
15. Peng ZZ, Hu GY, Shen H, et al. Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells. Nephrology (Carlton) 2009; 14: 565-572.
16. Liu J, Song C, Xiao Q, Hu G, Tao L, Meng J,. Fluorofenidone attenuates TGF-beta1-induced lung fibroblast activation via restoring the expression of Caveolin-1. Shock 2015; 43: 201-207.
17. Meng J, Zou Y, Hu C, et al. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway. Shock 2012; 38: 567-573.
18. Peng Y, Yang H, Wang N, et al. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2014; 306: G253-263.
19. Peng Y, Yang H, Zhu T, et al. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. Eur. J. Clin. Invest. 2013; 43: 358-368.
20. Ding Y, Kim SL, Lee SY, Koo JK, Wang Z, Choi ME,. Autophagy regulates TGF-beta expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction. J. Am. Soc. Nephrol. 2014; 25: 2835-2846.
21. Kim JH, Bogner PN, Ramnath N, Park Y, Yu J, Park YM,. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin. Cancer Res. 2007; 13: 3875-3882.
22. Winer J, Jung CK, Shackel I, Williams PM,. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 1999; 270: 41-49.
23. He P, Li D, Zhang B,. Losartan attenuates renal interstitial fibrosis and tubular cell apoptosis in a rat model of obstructive nephropathy. Mol. Med. Rep. 2014; 10: 638-644.
24. Bascands JL, Schanstra JP,. Obstructive nephropathy: Insights from genetically engineered animals. Kidney Int. 2005; 68: 925-937.
25. Kobayashi M, Sugiyama H, Wang DH, et al. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int. 2005; 68: 1018-1031.
26. Lieberthal W, Levine JS,. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 1996; 271 (3 Pt 2): F477-488.
27. Ophascharoensuk V, Giachelli CM, Gordon K, et al. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 1999; 56: 571-580.
28. Truong LD, Petrusevska G, Yang G, et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 1996; 50: 200-207.
29. Ho TC, Yang YC, Cheng HC, et al. Activation of mitogen-activated protein kinases is essential for hydrogen peroxide-induced apoptosis in retinal pigment epithelial cells. Apoptosis 2006; 11: 1899-1908.
30. Soini Y, Kallio JP, Hirvikoski P, et al. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS 2006; 114: 329-337.
31. Uwayama J, Hirayama A, Yanagawa T, et al. Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals. Biochem. Biophys. Res. Commun. 2006; 339: 226-231.
32. Yuan Q, Wang R, Peng Y, et al. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β1-induced fibroblast activation. Am. J. Nephrol. 2011; 34: 181-194.
33. Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A,. Mechanisms of renal apoptosis in health and disease. J. Am. Soc. Nephrol. 2008; 19: 1634-1642.
34. Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 2000; 58: 2301-2313.
35. Mao H, Li Z, Zhou Y, et al. HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am. J. Physiol. Renal Physiol. 2008; 295: F202-214.
36. Kumagai T, Osada Y, Ohta N, Kanazawa T,. Peroxiredoxin-1 from Schistosoma japonicum functions as a scavenger against hydrogen peroxide but not nitric oxide. Mol. Biochem. Parasitol. 2009; 164: 26-31.
37. Park KJ, Kim YJ, Kim J, et al. Protective effects of peroxiredoxin on hydrogen peroxide induced oxidative stress and apoptosis in cardiomyocytes. Korean Circ. J. 2012; 42: 23-32.